摘要
慢性乙型肝炎(CHB)是我国最常见的慢性传染病之一,其中HBeAg阴性CHB的患病率正在增加,对我国的卫生安全造成严重危害。综合HBeAg阴性CHB的发病机制、诊疗等方面,系统回顾了近年来的临床研究进展,对HBeAg阴性CHB诊疗的新进展进行综述。
Chronic hepatitis B(CHB)is one of the most common chronic infectious diseases in China,and the prevalence rate of HBeAg-negative CHB has been increasing year by year,causing serious harm to the security of public health in China.With reference to the pathogenesis,diagnosis,and treatment of HBeAg-negative CHB,this article reviews the clinical research advances in recent years and summarizes the new advances in the diagnosis and treatment of HBeAg-negative CHB.
作者
陈华仙
韦嘉
CHEN Huaxian;WEI Jia(Kunming Medical University,Kunming 650000,China;Department of Infectious Diseases and Hepatology,The Fourth Affiliated Hospital of Kunming Medical University,Kunming 650000,China)
出处
《临床肝胆病杂志》
CAS
北大核心
2020年第7期1612-1614,共3页
Journal of Clinical Hepatology
基金
云南省第二人民医院病毒性肝炎及相关肝病研究省创新团队(2015HC019)。
关键词
乙型肝炎
慢性
乙型肝炎E抗原
诊断
治疗学
hepatitis B
chronic
hepatitis B e antigens
diagnosis
therapeutics
